FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sharon Marsh

Research Profile

Occupations

Pharmacogenetics

Physiology

Concepts & Ideas

Gene Frequency

Genes & Molecular Sequences

Living Beings

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Sharon Marsh; howard mcleod; Eileen Dolan; Sunita J Shukla; Cara A Rabik; Li Gong; Tina Hernandez-Boussard; Xing Jian Lou; Teri E Klein; Russ B Altman
Platinum pathway.
Sharon Cresci; Philip G Jones; Carmen C Sucharov; Sharon Marsh; David E Lanfear; Adam Garsa; Michael Courtois; Carla J Weinheimer; Jun Wu; Michael A Province; Daniel P Kelly; howard mcleod; John A Spertus
Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
Jinsheng Yu; Robert R Freimuth; Robert Culverhouse; Sharon Marsh; Mark A Watson; howard mcleod
DNA methylotype analysis in colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sharon Marsh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Sharon Marsh; howard mcleod; Eileen Dolan; Sunita J Shukla; Cara A Rabik; Li Gong; Tina Hernandez-Boussard; Xing Jian Lou; Teri E Klein; Russ B Altman
Platinum pathway.
Pharmacogenetics and genomics 2009;19(7):563-4.
2008: Sharon Cresci; Philip G Jones; Carmen C Sucharov; Sharon Marsh; David E Lanfear; Adam Garsa; Michael Courtois; Carla J Weinheimer; Jun Wu; Michael A Province; Daniel P Kelly; howard mcleod; John A Spertus
Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
Pharmacogenomics 2008;9(10):1403-17.
2008: Jinsheng Yu; Robert R Freimuth; Robert Culverhouse; Sharon Marsh; Mark A Watson; howard mcleod
DNA methylotype analysis in colorectal cancer.
Oncology reports 2008;20(4):921-7.
2008: B F Gage; C Eby; J A Johnson; E Deych; M J Rieder; Paul M Ridker; Paul E Milligan; G Grice; P Lenzini; A E Rettie; C L Aquilante; L Grosso; Sharon Marsh; T Langaee; L E Farnett; D Voora; D L Veenstra; R J Glynn; A Barrett; howard mcleod
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
Clinical pharmacology and therapeutics 2008;84(3):326-31.
2008: Prabha Ranganathan; Robert Culverhouse; Sharon Marsh; Ami Mody; Tiffany J Scott-Horton; Richard Brasington; Amy Joseph; Virginia Reddy; Seth Eisen; howard mcleod
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
The Journal of rheumatology 2008;35(4):572-9.
2008: Janelle Hoskins; Eugenio Marcuello; Albert Altes; Sharon Marsh; Taylor Maxwell; Derek J Van Booven; Laia Pare Brunet; Robert Culverhouse; howard mcleod; Montserrat Baiget
Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1788-96.
2008: Sharon Marsh
Cancer pharmacogenetics.
Methods in molecular biology (Clifton, N.J.) 2008;448():437-46.
2007: Sharon Marsh; James Paul; Cristi R King; Gillian Gifford; howard mcleod; Robert Brown
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4528-35.
2007: Sharon Marsh; G Somlo; X Li; P Frankel; C R King; W D Shannon; howard mcleod; Timothy W Synold
Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer.
The pharmacogenomics journal 2007;7(5):362-5.
2007: David E Lanfear; Philip G Jones; Sharon Marsh; Sharon Cresci; John A Spertus; howard mcleod
Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome.
American heart journal 2007;154(3):561-6.
2007: Cristi R King; Ming Xiao; Jinsheng Yu; Matthew Minton; Nicholas J Addleman; Derek J Van Booven; Pui-Yan Kwok; howard mcleod; Sharon Marsh
Identification of NR1I2 genetic variation using resequencing.
European journal of clinical pharmacology 2007;63(6):547-54.
2007: David E Lanfear; Joshua M Stolker; Sharon Marsh; Michael W Rich; howard mcleod
Genetic variation in the B-type natiuretic peptide pathway affects BNP levels.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(1):55-62.
2007: Sharon Marsh; howard mcleod
Pharmacogenetics and oncology treatment for breast cancer.
Expert opinion on pharmacotherapy 2007;8(2):119-27.
2007: Sharon Marsh
Impact of pharmacogenomics on clinical practice in oncology.
Molecular diagnosis & therapy 2007;11(2):79-82.
2007: Nicola F Smith; Sharon Marsh; Tiffany J Scott-Horton; A Hamada; Stephan Mielke; Klaus Mross; William D Figg; Jaap Verweij; howard mcleod; Alex Sparreboom
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.
Clinical pharmacology and therapeutics 2007;81(1):76-82.
2007: Floris A de Jong; Tiffany J Scott-Horton; D L Kroetz; howard mcleod; Lena E Friberg; Ron H J Mathijssen; Jaap Verweij; Sharon Marsh; Alex Sparreboom
Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.
Clinical pharmacology and therapeutics 2007;81(1):42-9.
2007: Sharon Marsh
Pyrosequencing applications.
Methods in molecular biology (Clifton, N.J.) 2007;373():15-24.
2006: R M Engen; Sharon Marsh; Derek J Van Booven; howard mcleod
Ethnic differences in pharmacogenetically relevant genes.
Current drug targets 2006;7(12):1641-8.
2006: Noah M Hahn; Sharon Marsh; William Fisher; Robert Langdon; Robin Zon; Mark Browning; Cynthia S Johnson; Tiffany J Scott-Horton; Lang Li; howard mcleod; Christopher J Sweeney
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6094-9.
2006: Jinsheng Yu; Mary Ann Mallon; Wanghai Zhang; Robert R Freimuth; Sharon Marsh; Mark A Watson; Paul J Goodfellow; howard mcleod
DNA repair pathway profiling and microsatellite instability in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5104-11.
2006: Sharon Marsh; Derek J Van Booven; howard mcleod
Global pharmacogenetics: giving the genome to the masses.
Pharmacogenomics 2006;7(4):625-31.
2006: Sharon Marsh; howard mcleod
Pharmacogenomics: from bedside to clinical practice.
Human molecular genetics 2006;15 Spec No 1():R89-93.
2006: Patrick Cahan; Sharon Marsh; howard mcleod
Systems pharmacogenomics in yeast.
Pharmacogenomics 2006;7(2):255-9.
2005: Sharon Marsh
Pharmacogenetics of colorectal cancer.
Expert opinion on pharmacotherapy 2005;6(15):2607-16.
2005: Sharon Marsh; Mary Ann Mallon; Paul J Goodfellow; howard mcleod
Concordance of pharmacogenetic markers in germline and colorectal tumor DNA.
Pharmacogenomics 2005;6(8):873-7.
2005: Robert R Freimuth; Ming Xiao; Sharon Marsh; Matthew Minton; Nicholas Addleman; Derek J Van Booven; howard mcleod; Pui-Yan Kwok
Polymorphism discovery in 51 chemotherapy pathway genes.
Human molecular genetics 2005;14(23):3595-603.
2005: Anja Henningsson; Sharon Marsh; Walter J Loos; Mats O Karlsson; Adam Garsa; Klaus Mross; Stephan Mielke; Lucia Viganò; Alberta Locatelli; Jaap Verweij; Alex Sparreboom; howard mcleod
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8097-104.
2005: David E Lanfear; Philip G Jones; Sharon Marsh; Sharon Cresci; howard mcleod; John A Spertus
Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
JAMA : the journal of the American Medical Association 2005;294(12):1526-33.
2005: Adam A Garsa; howard mcleod; Sharon Marsh
CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
BMC medical genetics 2005;6():19.
2005: Melissa A Meucci; Sharon Marsh; James W Watters; howard mcleod
CEPH individuals are representative of the European American population: implications for pharmacogenetics.
Pharmacogenomics 2005;6(1):59-63.
2005: C R King; Jinsheng Yu; Robert R Freimuth; howard mcleod; Sharon Marsh
Interethnic variability of ERCC2 polymorphisms.
The pharmacogenomics journal 2005;5(1):54-9.
2004: Sharon Marsh; Ming Xiao; Jinsheng Yu; Ranjeet Ahluwalia; Matthew Minton; Robert R Freimuth; Pui-Yan Kwok; howard mcleod
Pharmacogenomic assessment of carboxylesterases 1 and 2.
Genomics 2004;84(4):661-8.
2004: Floris A de Jong; Sharon Marsh; Ron H J Mathijssen; Cristi King; Jaap Verweij; Alex Sparreboom; howard mcleod
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5889-94.
2004: David E Lanfear; Sharon Marsh; howard mcleod
Caution with beta1-adrenergic receptor genotyping.
Clinical pharmacology and therapeutics 2004;76(2):185-6; author reply 186.
2004: Alex Sparreboom; Sharon Marsh; Ron H J Mathijssen; Jaap Verweij; howard mcleod
Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients.
Investigational new drugs 2004;22(3):285-9.
2004: David E Lanfear; Sharon Marsh; Sharon Cresci; William D Shannon; John A Spertus; howard mcleod
Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans.
Journal of the American College of Cardiology 2004;44(1):165-7.
2004: Alex Sparreboom; Hans Gelderblom; Sharon Marsh; Ranjeet Ahluwalia; Rosendo Obach; Paola Principe; Chris Twelves; Jaap Verweij; howard mcleod
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype.
Clinical pharmacology and therapeutics 2004;76(1):38-44.
2004: Prabha Ranganathan; Robert Culverhouse; Sharon Marsh; Ranjeet Ahluwalia; William D Shannon; Seth Eisen; howard mcleod
Single nucleotide polymorphism profiling across the methotrexate pathway in normal subjects and patients with rheumatoid arthritis.
Pharmacogenomics 2004;5(5):559-69.
2004: David E Lanfear; Sharon Marsh; Sharon Cresci; John A Spertus; howard mcleod
Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure.
Pharmacogenomics 2004;5(5):553-8.
2004: Sharon Marsh; howard mcleod
Cancer pharmacogenetics.
British journal of cancer 2004;90(1):8-11.
2004: Sharon Marsh; Cristi R King; Ranjeet Ahluwalia; howard mcleod
Distribution of ITPA P32T alleles in multiple world populations.
Journal of human genetics 2004;49(10):579-81.
2003: Jinsheng Yu; Sharon Marsh; Ranjeet Ahluwalia; howard mcleod
Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer.
Cancer research 2003;63(19):6170-3.
2003: Ranjeet Ahluwalia; Robert R Freimuth; howard mcleod; Sharon Marsh
Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenase.
Clinical chemistry 2003;49(10):1661-4.
2003: Ron H J Mathijssen; Sharon Marsh; Mats O Karlsson; Rujia Xie; Sharyn D Baker; Jaap Verweij; Alex Sparreboom; howard mcleod
Irinotecan pathway genotype analysis to predict pharmacokinetics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3246-53.
2002: Sharon Marsh; Pui Kwok; howard mcleod
SNP databases and pharmacogenetics: great start, but a long way to go.
Human mutation 2002;20(3):174-9.
2001: Sharon Marsh; howard mcleod
Thymidylate synthase pharmacogenetics in colorectal cancer.
Clinical colorectal cancer 2001;1(3):175-8; discussion 179-81.